Crewe Advisors LLC acquired a new position in Xylem Inc. (NYSE:XYL – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,200 shares of the industrial products company’s stock, valued at approximately $155,000.
Several other hedge funds and other institutional investors have also modified their holdings of XYL. Kornitzer Capital Management Inc. KS lifted its position in Xylem by 9.0% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 109,882 shares of the industrial products company’s stock worth $12,566,000 after purchasing an additional 9,114 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its position in Xylem by 1,503.7% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock worth $188,685,000 after purchasing an additional 1,547,043 shares during the period. Duality Advisers LP bought a new position in Xylem in the first quarter worth $6,746,000. International Assets Investment Management LLC lifted its position in Xylem by 10,296.7% in the fourth quarter. International Assets Investment Management LLC now owns 63,004 shares of the industrial products company’s stock worth $7,205,000 after purchasing an additional 62,398 shares during the period. Finally, Vanguard Group Inc. lifted its position in Xylem by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock worth $3,207,683,000 after purchasing an additional 187,847 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Price Performance
Shares of Xylem stock traded up $0.42 during trading on Thursday, reaching $137.13. The company’s stock had a trading volume of 1,239,149 shares, compared to its average volume of 1,196,844. The stock has a 50-day moving average price of $138.60 and a two-hundred day moving average price of $130.08. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19. Xylem Inc. has a one year low of $87.59 and a one year high of $146.08. The stock has a market capitalization of $33.25 billion, a P/E ratio of 48.80, a price-to-earnings-growth ratio of 2.50 and a beta of 1.04.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 27th. Shareholders of record on Thursday, May 30th were issued a dividend of $0.36 per share. The ex-dividend date was Thursday, May 30th. This represents a $1.44 annualized dividend and a yield of 1.05%. Xylem’s dividend payout ratio is currently 51.25%.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. Royal Bank of Canada raised their target price on Xylem from $157.00 to $162.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. Mizuho lifted their price objective on Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, May 3rd. Robert W. Baird lifted their price objective on Xylem from $151.00 to $155.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Citigroup lifted their price objective on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Finally, TD Cowen lifted their price objective on Xylem from $135.00 to $138.00 and gave the company a “buy” rating in a report on Thursday, June 6th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $144.58.
Get Our Latest Stock Report on XYL
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- What is the Nikkei 225 index?
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- What is a buyback in stocks? A comprehensive guide for investors
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- How to Use Stock Screeners to Find Stocks
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.